1.
Rath J, Geisler C, Christiansen CB, Hastrup N, Madsen HO, Andersen MK, Pedersen LB, Jurlander J. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease. Haematologica [Internet]. 2008Aug.29 [cited 2026Nov.16];93(9):1424-6. Available from: https://haematologica.org/article/view/5014